ESC 365 - Comparative meta-analysis: drug-coated balloon versus drug-coated stent - a comprehensive evaluation of efficacy and safety in stentless percutaneous coronary intervention for coronary artery disease

Back

ESC Professional Premium Access

Comparative meta-analysis: drug-coated balloon versus drug-coated stent - a comprehensive evaluation of efficacy and safety in stentless percutaneous coronary intervention for coronary artery disease

Session: Medical and percutaneous treatment of coronary artery disease

Topic: Revascularisation

Event: ESC Congress 2024

Congress Presentation

Add to my library

7 more presentations in this session

Placebo-controlled efficacy of 17 anti-anginal drugs and percutaneous coronary intervention for first-line treatment of stable angina: systematic review & meta-analysis of 5153 patients from 53 trials

Speaker: Doctor A. Kaura (London, GB)

Three decades of lipid-lowering therapy in type 2 diabetic patients with angiographically proven stable coronary artery disease

Speaker: Associate Professor H. Drexel (Feldkirch, AT) Doctor A. Mader (Feldkirch, AT)

Persistent angina following revascularization for chronic coronary syndromes: a systematic review and meta-analysis of randomized controlled trials

Speaker: Doctor A. Singh (Los Angeles, US)

Effect of primary pci in asymptomatic stemi patients presenting 12 to 48 hours of symptom onset, on myocardial viability assessed by spect tc 99m sestamibi scan epitome99

Speaker: Doctor M. Pandit (Bangalore, India, IN)

Impact of symptom-to-balloon time on long-term prognosis: a 3-year follow-up study in non-st-segment elevation myocardial infarction patients with complex lesions

Speaker: Professor Y. Kim (Chuncheon, KR)

Access the full session

Medical and percutaneous treatment of coronary artery disease

Speakers: Doctor A. Kaura, Associate Professor H. Drexel, Doctor A. Mader, Doctor A. Singh, Doctor M. Pandit...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources